The prelude on novel receptor and ligand targets involved in the treatment of diabetes mellitus.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Advanced Pharmaceutical Bulletin

• Publication date

  2014-02-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.5681/apb.2014.031PMID 24754003PMCID PMC3992955
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurotensin and its receptors in the control of glucose homeostasis

  2012cited by this paper
• Adiponectin dysregulation and insulin resistance in type 1 diabetes.

  2012cited by this paper
• The A2b Adenosine Receptor Modulates Glucose Homeostasis and Obesity

  2012cited by this paper
• Small molecule inhibitors of PTP1B and TCPTP

  2012cited by this paper
• Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels.

  2012cited by this paper
• The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications.

  2012cited by this paper
• Toll-like receptors and diabetes: a therapeutic perspective.

  2012cited by this paper
• The Role of Glucose Transporters in Brain Disease: Diabetes and Alzheimer’s Disease

  2012cited by this paper
• The calcium-sensing receptor: a molecular perspective.

  2011cited by this paper
• Insulinotropic and antidiabetic effects of 17β-estradiol and the GPR30 agonist G-1 on human pancreatic islets.

  2011cited by this paper
• Possible signaling cascades involved in attenuation of alloxan-induced oxidative stress and hyperglycemia in mice by ethanolic extract of Syzygium jambolanum: drug-DNA interaction with calf thymus DNA as target.

  2011cited by this paper
• Sodium–glucose transport: role in diabetes mellitus and potential clinical implications

  2010cited by this paper
• Global estimates of the prevalence of diabetes for 2010 and 2030.

  2010cited by this paper
• The bile acid sensor FXR regulates insulin transcription and secretion.

  2010cited by this paper
• M3-muscarinic receptor promotes insulin release via receptor phosphorylation/arrestin-dependent activation of protein kinase D1

  2010cited by this paper
• Diabetes and microvascular pathophysiology: role of epidermal growth factor receptor tyrosine kinase

  2010cited by this paper
• TLR2 expression and signaling-dependent inflammation impair wound healing in diabetic mice

  2010cited by this paper
• Molecular mechanisms of insulin resistance in type 2 diabetes mellitus.

  2010cited by this paper
• Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice

  2010cited by this paper
• Suppression of Neurotensin Receptor Type 1 Expression and Function by Histone Deacetylase Inhibitors in Human Colorectal Cancers

  2010cited by this paper
• Peptidoglycan Enhances IL-6 Production in Human Synovial Fibroblasts via TLR2 Receptor, Focal Adhesion Kinase, Akt, and AP-1- Dependent Pathway1

  2009cited by this paper
• The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation

  2009cited by this paper
• Distinct Roles of Estrogen Receptor-α and β in the Modulation of Vascular Inducible Nitric-Oxide Synthase in Diabetes

  2009cited by this paper
• Trends in the Prevalence and Incidence of Diabetes in the UK

  2009cited by this paper
• The endocannabinoid system: a promising target for the management of type 2 diabetes.

  2009cited by this paper
• Trends in the prevalence and incidence of diabetes in the UK: 1996–2005

  2009cited by this paper
• The NALCN ion channel is activated by M3 muscarinic receptors in a pancreatic β-cell line

  2009cited by this paper
• Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition

  2008cited by this paper
• Mechanisms of Disease: advanced glycation end-products and their receptor in inflammation and diabetes complications

  2008cited by this paper
• EGF receptor in pancreatic beta-cell mass regulation.

  2008cited by this paper
• Lysophosphatidic acid regulates blood glucose by stimulating myotube and adipocyte glucose uptake

  2008cited by this paper
• Cholecystokinin activates pancreatic calcineurin-NFAT signaling in vitro and in vivo.

  2008cited by this paper
• Elevated Epidermal Growth Factor Receptor Phosphorylation Induces Resistance Artery Dysfunction in Diabetic db/db Mice

  2008cited by this paper
• Heat shock proteins: linking danger and pathogen recognition

  2007cited by this paper
• Cannabinoids go nuclear: evidence for activation of peroxisome proliferator‐activated receptors

  2007cited by this paper
• Toll-like Receptor 2 Senses β-Cell Death and Contributes to the Initiation of Autoimmune Diabetes

  2007cited by this paper
• Lysophosphatidic Acid Facilitates Proliferation of Colon Cancer Cells via Induction of Krüppel-like Factor 5*

  2007cited by this paper
• Involvement of PPARs in Cell Proliferation and Apoptosis in Human Colon Cancer Specimens and in Normal and Cancer Cell Lines

  2007cited by this paper
• Adenosine, an endogenous distress signal, modulates tissue damage and repair

  2007cited by this paper
• Endogenous TLR ligands and autoimmunity.

  2006cited by this paper
• Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes.

  2006cited by this paper
• The Farnesoid X Receptor Modulates Adiposity and Peripheral Insulin Sensitivity in Mice*

  2006cited by this paper
• Activation of the extracellular calcium-sensing receptor initiates insulin secretion from human islets of Langerhans: involvement of protein kinases.

  2006cited by this paper
• Cannabidiol lowers incidence of diabetes in non-obese diabetic mice

  2006cited by this paper
• Vitamin D and calcium intake in relation to type 2 diabetes in women.

  2006cited by this paper
• Farnesoid X receptor is essential for normal glucose homeostasis.

  2006cited by this paper
• Emerging targets for diabetes

  2005cited by this paper
• The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.

  2005cited by this paper
• Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes.

  2005cited by this paper
• Role of peroxisome proliferator-activated receptor-gamma in the glucose-sensing apparatus of liver and beta-cells.

  2004cited by this paper
• Bile Acids Regulate Gluconeogenic Gene Expression via Small Heterodimer Partner-mediated Repression of Hepatocyte Nuclear Factor 4 and Foxo1*

  2004cited by this paper
• Hyaluronan Fragments Stimulate Endothelial Recognition of Injury through TLR4*

  2004cited by this paper
• Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

  2004cited by this paper
• Endogenous ligands of Toll‐like receptors

  2004cited by this paper
• Elevated sialic acid, but not CRP, predicts features of the metabolic syndrome independently of BMI in women

  2004cited by this paper
• Diabetes Increases Facilitative Glucose Uptake and GLUT2 Expression at the Rat Proximal Tubule Brush Border Membrane

  2003cited by this paper
• Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins

  2003cited by this paper
• Adiponectin and protection against type 2 diabetes mellitus.

  2003cited by this paper
• Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production

  2002cited by this paper
• Y2 receptor deletion attenuates the type 2 diabetic syndrome of ob/ob mice.

  2002cited by this paper
• Different effects of oral administration of synthetic trypsin inhibitor on the pancreas between cholecystokinin-A receptor gene knockout mice and wild type mice.

  2002cited by this paper
• Protein tyrosine phosphatase 1B inhibitors for diabetes

  2002cited by this paper
• Estrogen and vascular function.

  2002cited by this paper
• Islet function phenotype in gastrin-releasing peptide receptor gene-deficient mice.

  2002cited by this paper
• Effects of Mutations in the Insulin-like Growth Factor Signaling System on Embryonic Pancreas Development and β-Cell Compensation to Insulin Resistance*

  2002cited by this paper
• PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein.

  2001cited by this paper
• Thiazolidinediones (PPARγ agonists) but not PPAR α agonists increase IRS‐2 gene expression in 3T3‐L1 and human adipocytes 1

  2001cited by this paper
• Clinical review 125: The insulin receptor and its cellular targets.

  2001cited by this paper
• Changes in Sodium or Glucose Filtration Rate Modulate Expression of Glucose Transporters in Renal Proximal Tubular Cells of Rat

  2001cited by this paper
• Thiazolidinediones (PPARgamma agonists) but not PPARalpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes.

  2001cited by this paper
• Insulin resistance and cardiovascular disease.

  2001cited by this paper
• Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function.

  2001cited by this paper
• The Insulin Receptor and Its Cellular Targets

  2001cited by this paper
• Pioglitazone Ameliorates Tumor Necrosis Factor-α–Induced Insulin Resistance by a Mechanism Independent of Adipogenic Activity of Peroxisome Proliferator–Activated Receptor-γ

  2001cited by this paper
• Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma.

  2001cited by this paper
• Neuropeptide Y and the adrenal gland: a review.

  2001cited by this paper
• T-1095, a renal Na+-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats.

  2000cited by this paper
• The effects of insulin-like growth factors on tumorigenesis and neoplastic growth.

  2000cited by this paper
• Insulin resistance and cardiovascular disease.

  2000cited by this paper
• Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes.

  1999cited by this paper
• Thiazolidinediones and insulin resistance: peroxisome proliferatoractivated receptor gamma activation stimulates expression of the CAP gene.

  1998cited by this paper
• The IRS-signalling system: A network of docking proteins that mediate insulin action

  1998cited by this paper
• Bombesin stimulates cholecystokinin secretion through mitogen-activated protein-kinase-dependent and -independent mechanisms in the enteroendocrine STC-1 cell line.

  1998cited by this paper
• Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog

  1997cited by this paper
• Studies on the Mechanisms by Which Gastrin Releasing Peptide Potentiates Glucose‐Induced Insulin Secretion from Mouse Islets

  1996cited by this paper
• A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*)

  1995cited by this paper
• Cholestyramine Therapy for Dyslipidemia in NonInsulin-dependent Diabetes Mellitus: A Short-Term, Double-Blind, Crossover Trial

  1994cited by this paper
• Crystal structure of the tyrosine kinase domain of the human insulin receptor

  1994cited by this paper
• Vesicular and cytoplasmic localization of neurotensin‐like immunoreactivity (NTLI) in neurons postsynaptic to terminals containing NTLI and/or tyrosine hydroxylase in the rat central nucleus of the amygdala

  1991cited by this paper
• Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin.

  1989cited by this paper
• Effects of L-364,718, a new cholecystokinin receptor antagonist, on camostate-induced growth of the rat pancreas.

  1988cited by this paper
• Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.

  1987cited by this paper
• G proteins and dual control of adenylate cyclase.

  1984cited by this paper
• Cell site and time course of DNA synthesis in pancreas after caerulein and secretin.

  1983cited by this paper

• Nanotechnology in diabetes Management: Revolutionizing treatment and diagnostics

  2024cites this paper
• A Comprehensive Review on Prospects of Polymeric Nanoparticles for Treatment of Diabetes Mellitus: Receptors-Ligands, In vitro & In vivo Studies.

  2023cites this paper
• Formulation of canagliflozin hemihydrate-loaded bilosomes for the treatment of Type-2 diabetes mellitus: In vitro, in vivo and in silico molecular docking studies

  2023cites this paper
• The Genetic Architecture of Meat Quality Traits in a Crossbred Commercial Pig Population

  2022cites this paper
• Drug Delivery Strategies for Enhancing the Therapeutic Efficacy of Toxin-Derived Anti-Diabetic Peptides

  2020cites this paper
• Comparative Studies on Safety of Glimepiride and Glipizide on Renal Microarchitecture and Oxidative Stress Markers of Pregnant Streptozotocin-Induced Diabetic Wistar Rats

  2019cites this paper
• Effects of atorvastatin on proteinuria of type 2 diabetic nephropathy in patients with history of gestational diabetes mellitus: A clinical study

  2017cites this paper
• Study on the Clinical Effects of Diabetic No. 1 Prescription of Traditional Chinese Medicine

  2016cites this paper
• Bloqueo de los receptores de mineralocorticoides y estimulación del sistema incretina en el tratamiento de la miocardiopatía diabética experimental

  2015cites this paper
• New Approaches to the Immunotherapy of Type 1 Diabetes Mellitus Using Interleukin-27.

  2015cites this paper
• Swim Training Improves HOMA-IR in Type 2 Diabetes Induced by High Fat Diet and Low Dose of Streptozotocin in Male Rats.

  2015cites this paper